Posted by Michael Wonder on 17 Nov 2016
FDA approves Intrarosa for postmenopausal women experiencing pain during sex
17 November 2016 - The U.S. FDA approved Intrarosa (prasterone) to treat women experiencing moderate to severe pain during sexual intercourse (dyspareunia), a symptom of vulvar and vaginal atrophy, due to menopause.
Intrarosa is the first FDA approved product containing the active ingredient prasterone, which is also known as dehydroepiandrosterone (DHEA).
